Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 39Colonic Neoplasms 10Neoplasms 8Stomach Neoplasms 7Neoplasm Metastasis 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Unresectable Metastatic Colorectal Cancer 2Liver Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Digestive System Neoplasms 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Rectal Neoplasms 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Neoplasm Recurrence, Local 1Melanoma 1Lung Neoplasms 1Intestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1

Interventions

elemene 2camrelizumab 1apatinib 1Oxaliplatin 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Primary Liver Cancer × Folfox protocol × Clear all
NCT03092895 2026-01-29

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
157 enrolled 17 charts
Gastrointestinal

Advanced Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡